Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02535338 |
|---|---|
| Brief Title: | Erlotinib Hydrochloride and Onalespib Lactate in Treating Patients With Recurrent or Metastatic EGFR-Mutant Non-small Cell Lung Cancer |
| First Submitted : | August 27, 2015 |
| First Submitted that Met QC Criteria : | August 27, 2015 |
| First Posted : | August 28, 2015 (Estimate) |
| Results First Submitted : | April 11, 2022 |
| Results First Submitted that Met QC Criteria : | May 31, 2022 |
| Results First Posted : | June 22, 2022 |
| Last Update Submitted that Met QC Criteria : | September 20, 2022 |
| Last Update Posted : | October 12, 2022 |